Articoli di riviste sul tema "Myers, Kevin"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-47 articoli di riviste per l'attività di ricerca sul tema "Myers, Kevin".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Macpherson, Jim. "Struggles for a Past: Irish and Afro-Caribbean Histories in England, 1951–2000. By Kevin Myers". Twentieth Century British History 30, n. 4 (18 settembre 2018): 618–20. http://dx.doi.org/10.1093/tcbh/hwy030.
Testo completoGerrard, Jessica. "Struggles for a past: Irish and Afro-Caribbean histories in England, 1951–2000, by Kevin Myers". History of Education 46, n. 4 (9 maggio 2016): 533–34. http://dx.doi.org/10.1080/0046760x.2016.1181798.
Testo completoArriens, C., A. Askanase, R. Furie, E. F. Morand, R. Van Vollenhoven, K. Connors, M. Davey et al. "AB0530 DESIGN OF 2 PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, GLOBAL TRIALS OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 (TYK2) INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 1463.1–1463. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3881.
Testo completoChoy, E., S. Henning, M. Brazil, K. Pollock, L. Groves, D. Sugrue e J. Houghton. "AB0347 TREATMENT RESPONSE WITH ABATACEPT PLUS METHOTREXATE TREATMENT FOR RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE FROM THE UK". Annals of the Rheumatic Diseases 81, Suppl 1 (23 maggio 2022): 1299.1–1299. http://dx.doi.org/10.1136/annrheumdis-2022-eular.2356.
Testo completoCurtis, J., K. Winthrop, B. Chan, S. Siegel, J. Stark, R. Suruki, R. Bohn et al. "FRI0314 ANNUAL DIAGNOSTIC PREVALENCE OF ANKYLOSING SPONDYLITIS (AS) IN THE UNITED STATES USING MEDICARE AND MARKETSCAN DATA". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 747.1–748. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4246.
Testo completoKorman, N. J., T. Passeron, K. B. Gordon, Y. Okubo, J. Bagel, H. Sofen, R. B. Warren et al. "AB1098 DEUCRAVACITINIB IN PLAQUE PSORIASIS: 2-YEAR LABORATORY RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 1774–75. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1533.
Testo completoDeodhar, A., K. Winthrop, R. Bohn, B. Chan, R. Suruki, J. Stark, H. Yun, S. Siegel, L. Chen e J. Curtis. "SAT0370 TUMOUR NECROSIS FACTOR INHIBITOR THERAPY DOES NOT REDUCE THE INCIDENCE OF COMORBIDITIES AND EXTRA-ARTICULAR MANIFESTATIONS IN ANKYLOSING SPONDYLITIS: AN ANALYSIS OF THREE US CLAIMS DATABASES". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 1132.1–1133. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4201.
Testo completoWinthrop, K., P. Nash, K. Yamaoka, E. Mysler, L. Calabrese, N. Khan, J. J. Enejosa, Y. Song, J. Suboticki e J. R. Curtis. "THU0218 INCIDENCE AND RISK FACTORS FOR HERPES ZOSTER IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING UPADACITINIB". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 335–36. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2744.
Testo completoAletaha, D., P. J. Mease, R. Lippe, F. Behrens, D. Haaland, P. Palominos, A. Lertratanakul et al. "POS1026 PREDICTORS FOR ACHIEVEMENT OF LOW DISEASE ACTIVITY AT WEEK 56 IN PATIENTS WITH PSORIATIC ARTHRITIS WHO RECEIVED UPADACITINIB 15 MG ONCE DAILY: POOLED ANALYSIS OF TWO PHASE 3 STUDIES". Annals of the Rheumatic Diseases 81, Suppl 1 (23 maggio 2022): 824.2–825. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1291.
Testo completoBaraliakos, X., R. Ranza, A. Ostor, F. Ciccia, L. Coates, S. Rednic, J. A. Walsh et al. "POS0934 EFFICACY OF UPADACITINIB ON PSORIATIC ARTHRITIS WITH AXIAL INVOLVEMENT DEFINED BY INVESTIGATOR ASSESSMENT AND PRO-BASED CRITERIA: RESULTS FROM TWO PHASE 3 STUDIES". Annals of the Rheumatic Diseases 81, Suppl 1 (23 maggio 2022): 768. http://dx.doi.org/10.1136/annrheumdis-2022-eular.722.
Testo completoRoth, Andreas. "Francis Stuart’s broadcasts from Germany, 1942—4: some new evidence". Irish Historical Studies 32, n. 127 (maggio 2001): 408–22. http://dx.doi.org/10.1017/s002112140001508x.
Testo completoGottlieb, A. B., F. Behrens, P. Nash, J. F. Merola, K. Ding, P. Pellet, L. Pricop e I. Mcinnes. "FRI0340 COMPARISON OF SECUKINUMAB VERSUS ADALIMUMAB EFFICACY ON SKIN OUTCOMES IN PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM THE EXCEED STUDY". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 763.2–764. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4736.
Testo completoLininger, N., S. Siegel, S. Kiwalkar, K. Winthrop, A. Ortega Loayza e A. Deodhar. "FRI0555 DO TNF INHIBITORS DECREASE RISK OF INCIDENT PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS COMPARED TO THOSE TREATED WITH METHOTREXATE ALONE?" Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 879.2–880. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4983.
Testo completoTurnage, Richard H., John L. Lanoue, Kevin M. Kadesky, Yan Meng e Stuart I. Myers. "Thromboxane A2 mediates increased pulmonary microvascular permeability after intestinal reperfusion". Journal of Applied Physiology 82, n. 2 (1 febbraio 1997): 592–98. http://dx.doi.org/10.1152/jappl.1997.82.2.592.
Testo completoStefanovska, Bojana, Kevin Lin, Benjamin Troness, Chad Myers e Reuben Harris. "Abstract P2-17-01: Targeted CRISPR screen to identify synthetic lethal combinations between APOBEC3B and DNA repair". Cancer Research 83, n. 5_Supplement (1 marzo 2023): P2–17–01—P2–17–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p2-17-01.
Testo completoMcinnes, I., F. Behrens, P. J. Mease, A. Kavanaugh, C. T. Ritchlin, P. Nash, J. Gratacos-Masmitja et al. "OP0227 SECUKINUMAB VERSUS ADALIMUMAB HEAD-TO-HEAD COMPARISON IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 52-WEEKS (EXCEED): A RANDOMISED, DOUBLE-BLIND, PHASE-3B STUDY". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 142–43. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4129.
Testo completoGenovese, M. C., K. Winthrop, Y. Tanaka, T. Takeuchi, A. Kivitz, F. Matzkies, L. Ye et al. "THU0202 INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 324–25. http://dx.doi.org/10.1136/annrheumdis-2020-eular.267.
Testo completoBykerk, V., A. B. Gottlieb, K. Reich, Y. Tanaka, K. Winthrop, C. Popova, N. Tilt e A. Blauvelt. "FRI0087 DURABILITY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIASIS OVER THREE YEARS: AN ANALYSIS OF POOLED CLINICAL TRIAL DATA". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 621.1–621. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1682.
Testo completoKITLV, Redactie. "Book Reviews". New West Indian Guide / Nieuwe West-Indische Gids 62, n. 3-4 (1 gennaio 1988): 165–209. http://dx.doi.org/10.1163/13822373-90002043.
Testo completoMease, P. J., A. Kavanaugh, D. D. Gladman, O. Fitzgerald, E. Soriano, P. Nash, D. Feng et al. "AB0529 CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 1294–95. http://dx.doi.org/10.1136/annrheumdis-2021-eular.574.
Testo completoHirano, A., W. Fujii, A. Sakashita, K. Baßler, M. Kadoya, A. Omoto, W. Fukuda et al. "POS0151 SINGLE-CELL RNA SEQUENCING OF BRONCHOALVEOLAR LAVAGE FLUID AND BLOOD REVEALS DISEASE-SPECIFIC CHARACTERISTICS OF IMMUNE CELLS IN CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE PATIENTS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 296–97. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2875.
Testo completoKavanaugh, A., P. J. Mease, K. Douglas, F. Behrens, D. Haaland, P. Palominos, A. Lertratanakul et al. "AB0547 ASSOCIATION BETWEEN ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION WITH IMPROVEMENT IN QUALITY OF LIFE IN UPADACITINIB-TREATED PATIENTS IN THE PHASE 3 SELECT-PsA 1 AND 2 STUDIES". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 1306.2–1307. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2000.
Testo completoMerola, J. F., I. Mcinnes, A. Kavanaugh, P. Nash, Z. Xue, V. Stakias, A. Eldred, S. Ciecinski, K. Douglas e L. Coates. "POS1029 EFFECTS OF TREATMENT WITH RISANKIZUMAB ON MINIMAL DISEASE ACTIVITY (MDA) AND DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (DAPSA): AN ANALYSIS OF THE KEEPsAKE-1 AND -2 TRIALS". Annals of the Rheumatic Diseases 81, Suppl 1 (23 maggio 2022): 827. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1362.
Testo completoMerrill, J. T., M. Smith, K. Thomas, C. Guthridge, N. Dominguez, S. Macwana, W. Dejager et al. "POS1154 PRE-TREATMENT DIFFERENTIALLY EXPRESSED METAGENES CHARACTERIZE SYSTEMIC LUPUS PATIENTS WHO SUBSEQUENTLY ACHIEVE CLINICAL RESPONSE TO BELIMUMAB". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 908–9. http://dx.doi.org/10.1136/annrheumdis-2023-eular.4022.
Testo completoFujii, W., A. Sakashita, A. Hirano, K. Baßler, M. Kadoya, A. Omoto, W. Fukuda et al. "POS0616 THE CHARACTERISTICS OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE IN CONNECTIVE TISSUE DISEASES WITH SINGLE-CELL RNA SEQUENCING OF BRONCHOALVEOLAR LAVAGE FLUID". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 580.1–581. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2140.
Testo completoGalloway, J., M. H. Buch, K. Yamaoka, C. Leatherwood, A. Pechonkina, I. Tiamiyu, D. Jiang et al. "OP0126 INFECTIONS AND SERIOUS INFECTIONS IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 70–71. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1416.
Testo completoCostello, R. E., J. Humphreys, K. Winthrop e W. Dixon. "SAT0065 TIMING OF PNEUMOCOCCAL VACCINATIONS IN RELATION TO STARTING DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 965.1–966. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1157.
Testo completoGenovese, M. C., J. S. Smolen, T. Takeuchi, G. R. Burmester, W. Deberdt, D. Schlichting, H. Song, D. Mo, C. Walls e K. Winthrop. "FRI0123 SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 642.1–643. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1723.
Testo completoWinter, Timothy, Timothy Myers, Leandro Colli, Lea Jessop, Jiyeon Choi, Mitchell J. Machiela, Mark P. Purdue, Kevin Brown e Stephen Chanock. "Abstract 6154: Targeted CRISPRi screen identifies functional variants and novel target genes at multiple renal cell carcinoma (RCC) susceptibility loci". Cancer Research 84, n. 6_Supplement (22 marzo 2024): 6154. http://dx.doi.org/10.1158/1538-7445.am2024-6154.
Testo completoWinthrop, K., D. Gold, D. Henrohn, L. Wang, A. Shapiro, H. Shi, G. Citera e H. Schulze-Koops. "SAT0139 AGE-BASED (<65 VS ≥65 YEARS) INCIDENCE OF INFECTIONS AND SERIOUS INFECTIONS IN TOFACITINIB-, ADALIMUMAB- AND PLACEBO-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, PHASE 3 AND PHASE 3B/4 TOFACITINIB STUDIES". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 1007–8. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1432.
Testo completoThakur, Rohit, Mai Xu, Alexandra Thornock, Hayley Sowards, Epring Long, Thomas Rheling, Karen Funderburk et al. "Abstract 5239: Integrative analysis of 3D chromatin organization at GWAS loci identifies RAPGEF1 as a melanoma susceptibility gene". Cancer Research 83, n. 7_Supplement (4 aprile 2023): 5239. http://dx.doi.org/10.1158/1538-7445.am2023-5239.
Testo completoHu, Fang Q., e Douglas M. Nark. "On a stabilization of the Ingard-Myers impedance boundary condition and its time domain implementation". International Journal of Aeroacoustics 23, n. 3-4 (9 maggio 2024): 318–41. http://dx.doi.org/10.1177/1475472x241230649.
Testo completoRims, C., V. Muir, K. Deane, S. Nagpal, N. Rao, F. Baribaud, G. Vratsanos et al. "THU0033 ALTERATIONS IN THE PHENOTYPIC LANDSCAPE AND SPECIFICITY OF CD4+ T CELLS IN CCP+ AT RISK SUBJECTS BEFORE THE ONSET OF RHEUMATOID ARTHRITIS". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 230.1–230. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1918.
Testo completoBurmester, G. R., K. Winthrop, R. Blanco, P. Nash, P. Goupille, V. F. Azevedo, C. Salvarani et al. "AB0522 SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS FROM THE PHASE 3 PROGRAM". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 1287–88. http://dx.doi.org/10.1136/annrheumdis-2021-eular.395.
Testo completoHu, Fang, e Douglas M. Nark. "A time domain boundary element method for acoustic scattering by lined surfaces in a subsonic uniform mean flow". Journal of the Acoustical Society of America 152, n. 4 (ottobre 2022): A118. http://dx.doi.org/10.1121/10.0015737.
Testo completoAi, R., D. Boyle, D. Hammaker, K. Deane, V. M. Holers, A. Matti, W. Robinson et al. "OP0337 DIFFERENTIAL METHYLATION OF PERIPHERAL BLOOD ADAPTIVE IMMUNE CELLS IN INDIVIDUALS AT HIGH RISK FOR RA AND WITH EARLY RA COMPARED WITH CONTROLS IDENTIFIES PATHWAYS IMPORTANT IN TRANSITION TO ARTHRITIS". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 207.2–207. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2989.
Testo completoPolinski, K., E. Bemis, K. Demoruelle, J. Seifert, T. Crume, F. Yang, W. Robinson et al. "SAT0596 ASSOCIATIONS BETWEEN CIRCULATING LIPID MEDIATORS AND INCIDENT INFLAMMATORY ARTHRITIS IN AN ANTI-CITRULLINATED PROTEIN ANTIBODY POSITIVE POPULATION". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 1256.1–1256. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1884.
Testo completoJenkins, Rhys. "R. Evan Ellis, China on the Ground in Latin America: Challenges for the Chinese and Impacts on the Region (Basingstoke and New York: Palgrave Macmillan, 2014), pp. xiii + 320, £72.00, hb. - Kevin P. Gallagher, The China Triangle: Latin America's China Boom and the Fate of the Washington Consensus (Oxford and New York: Oxford University Press, 2016), pp. xvii + 232, £18.99; $27.95, hb. - Margaret Myers and Carol Wise (eds.), The Political Economy of China–Latin America Relations in the New Millennium: Brave New World (New York and London: Routledge, 2017), pp. vii + 293, £29.99, pb. - Yanran Xu, China's Strategic Partnerships in Latin America: Case Studies of China's Oil Diplomacy in Argentina, Brazil, Mexico, and Venezuela, 1991–2015 (Lanham, MD: Lexington Books, 2017), pp. ix + 157, £52.95, hb." Journal of Latin American Studies 51, n. 1 (febbraio 2019): 187–91. http://dx.doi.org/10.1017/s0022216x19000014.
Testo completoLuo, Rui, Weelic Chong, Zhenchao Zhang, Maysa Abu-Khalaf, Daniel Silver, Frederick Fellin, Rebecca Jaslow et al. "Abstract P5-06-05: Whole-genome bisulfite sequencing of single circulating tumor cells identifies cellular methylation heterogeneity in metastatic breast cancer". Cancer Research 83, n. 5_Supplement (1 marzo 2023): P5–06–05—P5–06–05. http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-06-05.
Testo completoKITLV, Redactie. "Book Reviews". New West Indian Guide / Nieuwe West-Indische Gids 70, n. 1-2 (1 gennaio 1996): 133–203. http://dx.doi.org/10.1163/13822373-90002634.
Testo completoHengel, Richard L., Sujatha Krishnan, Jonathan A. Rosenberg, Timothy E. Ritter, Kathy A. Baker, Lucinda J. Van Anglen, Amy Guo, Mielad Moosapanah, Min Yang e Kevin W. Garey. "685. Early Experience with a Simple Administration of a Novel Fecal Microbiome Replacement for Prevention of Recurrent Clostridioides difficile". Open Forum Infectious Diseases 10, Supplement_2 (27 novembre 2023). http://dx.doi.org/10.1093/ofid/ofad500.747.
Testo completo"Recensions / Reviews". Canadian Journal of Political Science 34, n. 4 (dicembre 2001): 845–924. http://dx.doi.org/10.1017/s0008423901778110.
Testo completoRamos, Gabriel Teixeira. "CARTOGRAFIAS E MOVIMENTOS". Revista Jatobá 1 (18 dicembre 2019). http://dx.doi.org/10.54686/revjat.v1i.61326.
Testo completoCashman, Dorothy Ann. "“This receipt is as safe as the Bank”: Reading Irish Culinary Manuscripts". M/C Journal 16, n. 3 (23 giugno 2013). http://dx.doi.org/10.5204/mcj.616.
Testo completoBrien, Donna Lee. "Demon Monsters or Misunderstood Casualties?" M/C Journal 24, n. 5 (5 ottobre 2021). http://dx.doi.org/10.5204/mcj.2845.
Testo completoWilson, Shaun. "Situating Conceptuality in Non-Fungible Token Art". M/C Journal 25, n. 2 (25 aprile 2022). http://dx.doi.org/10.5204/mcj.2887.
Testo completoRyder, Paul, e Jonathan Foye. "Whose Speech Is It Anyway? Ownership, Authorship, and the Redfern Address". M/C Journal 20, n. 5 (13 ottobre 2017). http://dx.doi.org/10.5204/mcj.1228.
Testo completo